Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Atitaya Hitakarun, Maia Kavanagh Williamson, Nathamon Yimpring, Wannapa Sornjai, Nitwara Wikan, Christopher J. Arthur, Julien Pompon, Andrew D. Davidson & Duncan R. Smith. (2022) Cell Type Variability in the Incorporation of Lipids in the Dengue Virus Virion. Viruses 14:11, pages 2566.
Crossref
Crossref
Prince C. I. Umoke, MaryJoy Umoke, Nora Eyo, Adaeze Ugwu MBBS, Emmanuel Okeke, Chioma A. Nwalieji, Samson O. Agbaje, Rosemary N. Onwe, David O. Ekeh, Ugochi G. Umoke, Martins N. Agu & Charity C. Okide. (2021) Delay in health‐seeking behaviour: Implication to yellow fever outcome in the 2019 outbreak in Nigeria. Health & Social Care in the Community 29:3, pages 703-711.
Crossref
Crossref
Kimberly Berke, Peter Sun, Edison Ong, Nasim Sanati, Anthony Huffman, Timothy Brunson, Fred Loney, Joseph Ostrow, Rebecca Racz, Bin Zhao, Zuoshuang Xiang, Anna Maria Masci, Jie Zheng, Guanming Wu & Yongqun He. (2021) VaximmutorDB: A Web-Based Vaccine Immune Factor Database and Its Application for Understanding Vaccine-Induced Immune Mechanisms. Frontiers in Immunology 12.
Crossref
Crossref
Bryce M. Warner. (2021) Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response. Pathogens 10:3, pages 275.
Crossref
Crossref
Poliana de Oliveira Figueiredo, Ana Gabriella Stoffella-Dutra, Galileu Barbosa Costa, Jaqueline Silva de Oliveira, Carolina Dourado Amaral, Juliane Duarte Santos, Kamila Lorene Soares Rocha, João Pessoa Araújo Júnior, Maurício Lacerda Nogueira, Magno Augusto Zazá Borges, Adriano Pereira Paglia, Angelle Desiree LaBeaud, Jônatas Santos Abrahão, Erna Geessien Kroon, Danilo Bretas de Oliveira, Betânia Paiva Drumond & Giliane de Souza Trindade. (2020) Re-Emergence of Yellow Fever in Brazil during 2016–2019: Challenges, Lessons Learned, and Perspectives. Viruses 12:11, pages 1233.
Crossref
Crossref
Kyndall Dye-Braumuller, Chris Fredregill & Mustapha Debboun. 2020. Mosquitoes, Communities, and Public Health in Texas. Mosquitoes, Communities, and Public Health in Texas
249
278
.
Edison Ong, Peter Sun, Kimberly Berke, Jie Zheng, Guanming Wu & Yongqun He. (2019) VIO: ontology classification and study of vaccine responses given various experimental and analytical conditions. BMC Bioinformatics 20:S21.
Crossref
Crossref
Robin D.V. Kleinert, Eduardo Montoya-Diaz, Tanvi Khera, Kathrin Welsch, Birthe Tegtmeyer, Sebastian Hoehl, Sandra Ciesek & Richard J.P. Brown. (2019) Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus. Viruses 11:10, pages 960.
Crossref
Crossref
Nathalie Colin de Verdiere, Christine Durier, Assia Samri, Vincent Meiffredy, Odile Launay, Sophie Matheron, Séverine Mercier-Delarue, Sophie Even, Jean-Pierre Aboulker, Jean-Michel Molina, Brigitte Autran & François Simon. (2018) Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. AIDS 32:16, pages 2291-2299.
Crossref
Crossref
Tiffany F Kautz, Mathilde Guerbois, Kamil Khanipov, Edward I Patterson, Rose M Langsjoen, Ruimei Yun, Kelsey L Warmbrod, Yuriy Fofanov, Scott C Weaver & Naomi L Forrester. (2018) Low-fidelity Venezuelan equine encephalitis virus polymerase mutants to improve live-attenuated vaccine safety and efficacy. Virus Evolution 4:1.
Crossref
Crossref
Jie Zheng, Huan Li, Qingzhi Liu & Yongqun He. (2017) The Ontology of Biological and Clinical Statistics (OBCS)‐based statistical method standardization and meta‐analysis of host responses to yellow fever vaccines. Quantitative Biology 5:4, pages 291-301.
Crossref
Crossref
Carolina Colombelli Pacca, Rafael Elias Marques, José Wanderlan P. Espindola, Gevânio B.O.Oliveira Filho, Ana Cristina Lima Leite, Mauro Martins Teixeira & Mauricio L. Nogueira. (2017) Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus. Biomedicine & Pharmacotherapy 87, pages 381-387.
Crossref
Crossref
Akoï Koïvogui, Aurel Carbunar, Laure-Manuella Imounga, Christelle Laruade & Sylvaine Laube. (2017) Vaccination against yellow fever in French Guiana: The impact of educational level, negative beliefs and attitude towards vaccination. Travel Medicine and Infectious Disease 15, pages 37-44.
Crossref
Crossref
Panchali Roy Chowdhury, Christian Meier, Hewad Laraway, Yuxiao Tang, Abraham Hodgson, Samba O. Sow, Godwin C. Enwere, Brian D. Plikaytis, Prasad S. Kulkarni, Marie-Pierre Preziosi & Matthias Niedrig. (2015) Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali. Clinical Infectious Diseases 61:suppl_5, pages S586-S593.
Crossref
Crossref
Dhiraj Acharya, Amber M. Paul, John F. Anderson, Faqing Huang & Fengwei Bai. (2015) Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity. PLOS Neglected Tropical Diseases 9:10, pages e0004139.
Crossref
Crossref
Elin Petterson, Tz-Chun Guo, Øyvind Haugland, Øystein Evensen & Aase B. Mikalsen. (2015) In vitro adaptation of SAV3 in cell culture correlates with reduced in vivo replication capacity and virulence to Atlantic salmon (Salmo salar L.) parr. Journal of General Virology 96:10, pages 3023-3034.
Crossref
Crossref
Christina L. Gardner, Jozef Hritz, Chengqun Sun, Dana L. Vanlandingham, Timothy Y. Song, Elodie Ghedin, Stephen Higgs, William B. Klimstra & Kate D. Ryman. (2014) Deliberate Attenuation of Chikungunya Virus by Adaptation to Heparan Sulfate-Dependent Infectivity: A Model for Rational Arboviral Vaccine Design. PLoS Neglected Tropical Diseases 8:2, pages e2719.
Crossref
Crossref
J.E. Snyder, J. Jose & R.J. Kuhn. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
James Bagonza, Elizeus Rutebemberwa, Malimbo Mugaga, Nathan Tumuhamye & Issa Makumbi. (2013) Yellow fever vaccination coverage following massive emergency immunization campaigns in rural Uganda, May 2011: a community cluster survey. BMC Public Health 13:1.
Crossref
Crossref
Luca Cegolon, Cristiano Salata, Elisabete Weiderpass, Paolo Vineis, Giorgio Palù & Giuseppe Mastrangelo. (2013) Human endogenous retroviruses and cancer prevention: evidence and prospects. BMC Cancer 13:1.
Crossref
Crossref
Lawrence J. Hribar. (2013) Influence and Impact of Mosquito-borne Diseases on the History of Florida, USA. Life: The Excitement of Biology 1:1, pages 53-68.
Crossref
Crossref
Thomas P. Monath, Mark Gershman, J. Erin Staples & Alan D.T. Barrett. 2013. Vaccines. Vaccines
870
968
.
Darius Soonawala, Anna M. van Eggermond, Herma Fidder & Leo G. Visser. (2012) Pretravel preparation and travel-related morbidity in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 18:11, pages 2079-2085.
Crossref
Crossref
M. Alberer & H.D. Nothdurft. (2012) Ikterus nach ReisenIcterus after travelling. Der Gastroenterologe 7:3, pages 213-219.
Crossref
Crossref
Michael A. Johansson, Brad J. Biggerstaff, Neysarí Arana-Vizcarrondo, Nancy Gallagher, J. Erin Staples & Nina Marano. (2012) Assessing the Risk of International Spread of Yellow Fever Virus: A Mathematical Analysis of an Urban Outbreak in Asunción, 2008. The American Journal of Tropical Medicine and Hygiene 86:2, pages 349-358.
Crossref
Crossref
Helge Kampen, Mandy Kronefeld & Doreen Werner. 2012. Arthropods as Vectors of Emerging Diseases. Arthropods as Vectors of Emerging Diseases
1
30
.
Leo G. Visser. (2011) TNF-α Antagonists and Immunization. Current Infectious Disease Reports 13:3, pages 243-247.
Crossref
Crossref
Patrice Bourée, Francine Bisaro, Sophie Delaigue, Nagiro Djibo & Paula Resende. (2011) Le diagnostic de la fièvre jaune. Revue Francophone des Laboratoires 2011:430, pages 27-32.
Crossref
Crossref
Pantelis Topalis, Emmanuel Dialynas, Elvira Mitraka, Elena Deligianni, Inga Siden-Kiamos & Christos Louis. (2011) A set of ontologies to drive tools for the control of vector-borne diseases. Journal of Biomedical Informatics 44:1, pages 42-47.
Crossref
Crossref
Malcolm S. Duthie, Hillarie Plessner Windish, Christopher B. Fox & Steven G. Reed. (2011) Use of defined TLR ligands as adjuvants within human vaccines. Immunological Reviews 239:1, pages 178-196.
Crossref
Crossref
A. H. E. Roukens, L. B. S. Gelinck & L. G. Visser. 2012. Intradermal Immunization. Intradermal Immunization
159
179
.
Morton Scheinberg, Luis Sergio Guedes-Barbosa, Cristovao Mangueira, Eliane Aparecida Rosseto, Licia Mota, Ana Cristina Oliveira & Rodrigo Aires Lima. (2010) Yellow fever revaccination during infliximab therapy. Arthritis Care & Research 62:6, pages 896-898.
Crossref
Crossref
Carolyn Driver. (2010) Yellow fever. Practice Nursing 21:4, pages 201-205.
Crossref
Crossref
Simon J. Draper & Jonathan L. Heeney. (2009) Viruses as vaccine vectors for infectious diseases and cancer. Nature Reviews Microbiology 8:1, pages 62-73.
Crossref
Crossref